- ¥1650 - 2680
- KALANG
- 见说明书
- 美国/中国
- KL-E09412h
- 2025年08月10日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
1000
- 供应商：
康朗生物
- 检测范围：
见说明书
- 检测方法：
酶联免疫
- 应用：
科研
- 标记物：
HRP标记物
- 样本：
血清/组织/尿液
Human advanced glycation end products,AGEs ELISA Kit
标准曲线:These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
µg/ml OD1 OD2 Average Corrected
50 2.698 2.652 2.675 2.534
25 2.076 2.082 2.079 1.938
12.5 1.204 1.283 1.244 1.103
6.25 0.639 0.669 0.654 0.513
3.12 0.388 0.374 0.381 0.240
1.56 0.261 0.259 0.260 0.119
0.78 0.187 0.179 0.183 0.042
0 0.145 0.137 0.141
Human advanced glycation end products,AGEs ELISA Kit
精密度:Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Human advanced glycation end products,AGEs ELISA Kit
线性度:To assess the linearity of the assay, samples were spiked with high concentrations of human AGEs in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
Sample Serum(n=4)
1:1 Average % 84
Range % 80-89
1:2 Average % 90
Range % 85-95
1:4 Average % 94
Range % 90-99
1:8 Average % 104
Range % 100-109
Human advanced glycation end products,AGEs ELISA Kit
回收率:The recovery of human AGEs spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range
Serum (n=5) 92 88-96
EDTA plasma (n=4) 97 92-101
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Advanced glycation endproducts (AGEs) are stable end-stage adducts formed by the nonenzymatic reaction of saccharide derivatives with proteins, nucleotides, and phospholipids. They are formed in physiological systems by glycation reactions
Autofluorescent Ceroid/Lipofuscin
.g., in the kidney, thymus, pancreas, testis, prostate, seminal vesicles, uterus, and adrenal gland of man and animal (1 –4 ). Advanced glycation end-products (AGEs) are mainly found extracellularly in association with long-lived proteins, e.g
. The more important protein modifications are referred to as advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs). Protein modification can result in both non-cross-link and cross-link AGEs and ALEs, the latter arising
技术资料暂无技术资料 索取技术资料
